Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #141502 on Biotech Values
biotech jim
05/07/12 9:26 PM
#141508 RE: DewDiligence #141502
genisi
05/09/12 3:53 PM
#141660 RE: DewDiligence #141502
The panel voted 8 to 2 saying the clinical data submitted by Pfizer supported the approval of tofacitinib in patients who have failed with at least one other drug.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads